- World's largest repository of sleep data – a giant step
forward for sleep medicine
- Predictive analytics from data will improve therapy and
outcomes for sleep patients
- Milestone reinforces ResMed's leadership in remote patient
monitoring industry
SAN DIEGO, Jan. 4, 2017 /CNW/ -- ResMed (NYSE:RMD) today
announced that it has achieved a new record in digital connected
care: One billion nights of sleep data have been downloaded using
ResMed's revolutionary remote patient monitoring platform,
AirView™.
"One billion isn't just a big number," said Atul Malhotra, MD, chief of the Division of
Pulmonary and Critical Care Medicine and director of Sleep Medicine
at UC San Diego Health. "It's a major milestone that holds great
promise for future research and the treatment of sleep apnea and
other respiratory conditions through connected health tools."
"We are about to enter a new phase of sleep research and sleep
understanding," said Malhotra, also immediate past president of the
American Thoracic Society, "using big data to improve patients'
well-being."
Meaningful digital health solutions did not exist in respiratory
medicine until ResMed led the market with 100% cloud connected
respiratory medical devices. Since ResMed first enabled physicians
and sleep specialists to remotely monitor CPAP patients in 2004,
its safe and securely transferred data has helped them quickly
identify which patients are experiencing therapy issues, improving
both patient health outcomes and business efficiency for healthcare
providers.
"This unprecedented amount of data enables predictive analytics
to help physicians and providers better manage patients' sleep
apnea and COPD therapy, and ultimately improve their overall
health," said Mick Farrell, ResMed
CEO. "Reaching one billion nights is about more than just
big data; it's a testament to how the adoption and meaningful
use of technology benefits patients, physicians, and providers
everywhere, and we couldn't be more pleased to start 2017 with
this exciting news – this is just the beginning!"
ResMed is the world's leading provider of connected care
solutions in the home, with more than three million patients being
monitored by AirView, more than 200,000 diagnostic tests processed
in the cloud, and more than 1,000 patients per day signing up for
myAir™ to track their own therapy use on ResMed Air10™ devices.
The remote patient monitoring market is expected to become a
$30 billion industry by 2020,
according to tech analyst firm Berg Insight.
Sleep centers are also excited about ResMed's milestone and the
general advancement of remote monitoring.
"We've come so far from the days of manual data gathering, one
patient at a time," said Sharon
Schutte-Rodin MD, Clinical Professor of Medicine at UPenn's
Perelman School of Medicine. "Integrating ResMed's CPAP data into
Epic helps us better track visit documentation, triggered
workflows, internal benchmarks, and outcomes. The prospect of
viewing data across populations to further personalize and improve
patients' care is very exciting."
About ResMed
ResMed (NYSE:RMD) changes lives with
award-winning medical devices and cutting-edge cloud-based software
applications that better diagnose, treat and manage sleep apnea,
chronic obstructive pulmonary disease (COPD) and other chronic
diseases. ResMed is a global leader in connected care, with more
than 2 million patients remotely monitored every day. Our
5,000-strong team is committed to creating the world's best
tech-driven medical device company – improving quality of life,
reducing the impact of chronic disease, and saving healthcare costs
in more than 100 countries.
ResMed.com | Facebook | Twitter | LinkedIn
For
media:
|
For
investors:
|
Alison
Graves
|
Agnes Lee
|
Director, Corporate
Communications
|
Senior Director,
Investor Relations
|
O:
858-836-6789
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/resmed-reaches-historic-one-billionth-night-of-sleep-monitored-300385071.html
SOURCE ResMed Inc.